Aardvark Therapeutics Market Sentiment

Aardvark Therapeutics Inc

AARDNASDAQ

Trade with Public

$4.99

-0.28-5.31%

最終更新: Oct 2, 4:35 PM

$5.00

-0.27-5.12%

概要ニュース業績予想イベント目標株価財務センチメント株主構成比較オプション株式レポート

Aardvark Therapeutics Market Sentiment - Benzinga

Aardvark Therapeutics Market Sentiment

Market sentiment signals for Aardvark Therapeutics (AARD): analyst consensus, short interest, options flow and insider activity.

Key Signals

Analyst Consensus▲ Buy

Short Interest▲ 2.9% short float

Options Flow— N/A

Insider Activity▼ Net Seller (30d)

Analyst Consensus

Buy

11 analysts

Options Flow (P/C)

—

Avg Consensus PT

$13

+167.6%

Highest Price Target

$33

+560.0%

Jones Trading

Lowest Price Target

-40.0%

Morgan Stanley

Short Interest

2.9%

Declining — Bullish

Insider Activity (30d)

Net Seller

Short Interest — % of Float

Recent Analyst Actions

Date	Firm	Analyst & Accuracy	Upside / Downside	PT Change	Action	Rating
Sep 24, 2026	RBC Capital	Brian Abrahams—	+20.0%	$6 → $6	Maintained	Sector Perform
Jul 20, 2026	HC Wainwright & Co.	Raghuram Selvaraju—	+20.0%	$6	Maintained	Neutral
May 15, 2026	B. Riley Securities	William Woods—	+40.0%	$8 → $7	Maintained	Buy
May 15, 2026	BTIG	Jeet Mukherjee —	—	—	Downgrade	Buy→Neutral
May 15, 2026	Morgan Stanley	Michael Ulz—	-40.0%	$7 → $3	Downgrade	Equal-Weight→Underweight
Mar 24, 2026	BTIG	Jeet Mukherjee —	+80.0%	$9 → $9	Maintained	Buy
Mar 2, 2026	Oppenheimer	Leland Gershell—	+320.0%	$35 → $21	Maintained	Outperform
Mar 2, 2026	BTIG	Jeet Mukherjee —	+80.0%	$26 → $9	Maintained	Buy
Mar 2, 2026	HC Wainwright & Co.	Raghuram Selvaraju—	—	—	Downgrade	Buy→Neutral
Mar 2, 2026	Morgan Stanley	Michael Ulz—	+40.0%	$29 → $7	Downgrade	Overweight→Equal-Weight
Mar 2, 2026	Stifel	James Condulis—	+20.0%	$24 → $6	Downgrade	Buy→Hold
Mar 2, 2026	RBC Capital	Brian Abrahams—	+20.0%	$18 → $6	Downgrade	Outperform→Sector Perform
Feb 10, 2026	BTIG	Jeet Mukherjee —	+420.0%	$26 → $26	Maintained	Buy
Feb 9, 2026	HC Wainwright & Co.	Raghuram Selvaraju—	+700.0%	$40 → $40	Maintained	Buy
Dec 23, 2025	Oppenheimer	Leland Gershell—	+600.0%	$35	Initiate	Outperform
Dec 12, 2025	William Blair	Andy Hsieh—	—	—	Initiate	Outperform
Nov 14, 2025	RBC Capital	Brian Abrahams—	+260.0%	$19 → $18	Maintained	Outperform
Nov 7, 2025	BTIG	Jeet Mukherjee —	+420.0%	$26	Initiate	Buy
Oct 1, 2025	Jones Trading	Catherine Novack—	+560.0%	$33	Initiate	Buy
Sep 29, 2025	Stifel	James Condulis—	+380.0%	$24	Initiate	Buy
Sep 23, 2025	HC Wainwright & Co.	Raghuram Selvaraju—	+700.0%	$40 → $40	Maintained	Buy
Aug 28, 2025	B of A Securities	Tim Anderson—	+400.0%	$26 → $25	Maintained	Buy
Aug 14, 2025	RBC Capital	Brian Abrahams—	+280.0%	$20 → $19	Maintained	Outperform
Jun 30, 2025	HC Wainwright & Co.	Raghuram Selvaraju—	+700.0%	$40	Initiate	Buy
May 15, 2025	RBC Capital	Brian Abrahams—	+300.0%	$21 → $20	Maintained	Outperform

More with Benzinga EdgeGet Access

Aardvark Therapeutics Inc

ニュース

パートナーシップ

ベンジンガ・グローバル

Aardvark Therapeutics Market Sentiment

Bulls vs Bears

Key Signals

Recent Analyst Actions

People Also Watch

Bulls vs Bears

People Also Watch